This disruption in signaling pathways is a critical factor in tumor formation (Costa et al., 2017; Yewale et al., 2013), particularly in lung cancer, where EGFR plays a vital role (Peifer et al., 2012). This evidence concerns the gene EGFR and lung carcinoma.